Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wout Arras

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|July 16, 2021
Proliferation Increasing Genetic Engineering in Human Corneal Endothelial Cells: A Literature ReviewWout Arras, Hendrik Vercammen, Sorcha Ní Dhubhghaill, et al.
Inflammatory Bowel Diseases|November 24, 2025
Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational ModificationsWout Arras, Baptiste Oosterlinck, Julie Gassman, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2022
The role of mucins in gastrointestinal barrier function during health and diseaseTom Breugelmans, Baptiste Oosterlinck, Wout Arras, et al.
Inflammatory Bowel Diseases|October 14, 2022
Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and ActivityTom Breugelmans, Wout Arras, Lauren-Emma Boen, et al.
Cells|May 13, 2023
IL-22-Activated <i>MUC13</i> Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK SignalingTom Breugelmans, Wout Arras, Baptiste Oosterlinck, et al.
Journal of Crohn'S & Colitis|September 27, 2024
The Intestinal Mucin Isoform Landscape Reveals Region-Specific Biomarker Panels for Inflammatory Bowel Disease Patient StratificationWout Arras, Tom Breugelmans, Baptiste Oosterlinck, et al.
Microbiome|April 21, 2023
Mucin-microbiome signatures shape the tumor microenvironment in gastric cancerBaptiste Oosterlinck, Hannah Ceuleers, Wout Arras, et al.
JCI Insight|August 27, 2021
A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severityAnnemieke Smet, Tom Breugelmans, Johan Michiels, et al.
Cell Death and Differentiation|July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|July 16, 2021
Proliferation Increasing Genetic Engineering in Human Corneal Endothelial Cells: A Literature ReviewWout Arras, Hendrik Vercammen, Sorcha Ní Dhubhghaill, et al.
Inflammatory Bowel Diseases|November 24, 2025
Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational ModificationsWout Arras, Baptiste Oosterlinck, Julie Gassman, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2022
The role of mucins in gastrointestinal barrier function during health and diseaseTom Breugelmans, Baptiste Oosterlinck, Wout Arras, et al.
Inflammatory Bowel Diseases|October 14, 2022
Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and ActivityTom Breugelmans, Wout Arras, Lauren-Emma Boen, et al.
Cells|May 13, 2023
IL-22-Activated <i>MUC13</i> Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK SignalingTom Breugelmans, Wout Arras, Baptiste Oosterlinck, et al.
Journal of Crohn'S & Colitis|September 27, 2024
The Intestinal Mucin Isoform Landscape Reveals Region-Specific Biomarker Panels for Inflammatory Bowel Disease Patient StratificationWout Arras, Tom Breugelmans, Baptiste Oosterlinck, et al.
Microbiome|April 21, 2023
Mucin-microbiome signatures shape the tumor microenvironment in gastric cancerBaptiste Oosterlinck, Hannah Ceuleers, Wout Arras, et al.
JCI Insight|August 27, 2021
A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severityAnnemieke Smet, Tom Breugelmans, Johan Michiels, et al.
Cell Death and Differentiation|July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Pageof 1